Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients.
Scaltriti M, Eichhorn PJ, Cortés J, Prudkin L, Aura C, Jiménez J, Chandarlapaty S, Serra V, Prat A, Ibrahim YH, et al. Proc Natl Acad Sci U S A. 2011 Mar 1; 108(9):3761-6. Epub 2011 Feb 14.